Filter News
Area of Research
- (-) Neutron Science (14)
- (-) Supercomputing (24)
- Biological Systems (1)
- Biology and Environment (23)
- Clean Energy (16)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (5)
- Materials (9)
- Materials for Computing (5)
- National Security (4)
- Nuclear Science and Technology (3)
News Topics
- (-) Biomedical (25)
- (-) Coronavirus (17)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (2)
- Artificial Intelligence (39)
- Big Data (20)
- Bioenergy (13)
- Biology (14)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (17)
- Composites (1)
- Computer Science (98)
- Critical Materials (3)
- Cybersecurity (9)
- Decarbonization (7)
- Energy Storage (14)
- Environment (28)
- Exascale Computing (22)
- Fossil Energy (1)
- Frontier (29)
- Fusion (2)
- Grid (5)
- High-Performance Computing (39)
- Isotopes (1)
- Machine Learning (16)
- Materials (28)
- Materials Science (33)
- Mathematics (1)
- Microscopy (8)
- Molten Salt (1)
- Nanotechnology (19)
- National Security (8)
- Net Zero (1)
- Neutron Science (101)
- Nuclear Energy (7)
- Partnerships (1)
- Physics (16)
- Polymers (3)
- Quantum Computing (19)
- Quantum Science (29)
- Security (6)
- Simulation (14)
- Software (1)
- Space Exploration (5)
- Summit (42)
- Sustainable Energy (11)
- Transportation (10)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.